1.5T MR-Linac 小边界每周自适应方案对胶质母细胞瘤危及器官保护的评价
该研究基于 UNITED 2 期前瞻性试验,对 29 例胶质母细胞瘤患者(60 Gy/30 次)的剂量学数据进行回顾性再计划,比较 5 mm CTV 小边界每周自适应方案(PUNITED)与常规边界非自适应方案(PConv)对危及器官和目标覆盖的影响。结果显示 PUNITED 显著降低正常脑受照体积及脑干、视交叉最大剂量,同时维持目标覆盖;但常规边界剂量分布应用于每周自适应轮廓时,10/29 例出现目标覆盖欠佳,5 例 CTV D98% 低于 50 Gy。
要点
- 小边界每周自适应方案显著降低正常脑 V60Gy 及脑干、视交叉最大剂量。
- 常规边界剂量分布用于每周自适应轮廓时,10/29 例目标覆盖欠佳。
- 5 例患者 CTV D98% 低于 50 Gy,提示自适应对维持覆盖的重要性。
核心结论
- UNITED 小边界每周自适应方案在维持目标覆盖的同时改善危及器官保护并减少正常脑受照体积。
研究设计与样本
- 基于 UNITED 2 期前瞻性试验的回顾性剂量学研究,纳入 29 例接受 60 Gy/30 次治疗的胶质母细胞瘤患者。
- 每例患者分析 6 个每周自适应计划和 1 个常规边界非自适应计划,比较 PUNITED 与 PConv 的危及器官剂量指标。
- 统计采用 Friedman 检验及 Nemenyi 事后分析,α=0.005 并校正多重比较。
主要发现
- 正常脑中位 V60Gy 从 PConv 的 146.3–157.3 cm³ 降至 PUNITED 的 84.2–93.4 cm³(P<.0001)。
- 脑干中位最大剂量从 56.1 Gy 降至 49.0 Gy(P=.0001),视交叉从 41.5 Gy 降至 38.4 Gy(P<.0001)。
- 常规边界剂量分布应用于每周自适应轮廓时,10/29 例目标覆盖欠佳,其中 5 例 CTV D98% 低于 50 Gy。
关键数值与推荐
- UNITED 方案采用 5 mm CTV 边界,对照常规 1.5–3 cm CTV 边界。
- 通过每周钆对比剂增强及基于机载 MR 图像对 GTV 变化进行自适应。
- 处方剂量为 60 Gy 分 30 次。
临床怎么用
- 对胶质母细胞瘤采用小边界每周 MR 自适应放疗可减少正常脑及关键危及器官受量。
- 不能将常规边界剂量分布直接套用于每周自适应轮廓,否则可能导致目标覆盖不足。
局限性
- 本研究为回顾性再计划分析,样本量 29 例。
- 原文未报告长期临床结局或毒性随访数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess the dosimetric impact on organs-at-risk (OARs) and target coverage of a small-margin weekly adaptive treatment for glioblastoma delivered on an MR-Linac. METHODS AND MATERIALS: The UNIty-Based MR-Linac Guided AdapTive Radiation thErapy for High GraDe Glioma (UNITED) phase 2 prospective trial used a 5 mm clinical target volume (CTV) margin compared to conventional 1.5 to 3 cm CTV margins. Margin reduction was supported by weekly administration of gadolinium contrast and adaptation to gross tumor volume changes using onboard MR imaging. In the present study, dosimetric data from 29 patients with UNITED plans (PUNITED) treated with 60 Gy in 30 fractions were retrospectively replanned with conventional margins (PConv) and compared. For each patient, 6 weekly adapted and 1 conventional margin nonadapted plan were included in the analysis. Relevant OAR dose metrics were compared using Friedman tests followed by Nemenyi post hoc analysis (α = 0.005, corrected for multiple comparisons). RESULTS: A substantial and statistically significant reduction in irradiated normal brain volume was achieved with the median V60Gy lowered from 146.3-157.3 cm3 (range of median weekly values) with PConvto 84.2-93.4 cm3 for PUNITED (P < .0001). The median max dose to the brainstem and optic chiasm was reduced from 56.1 Gy to 49.0 Gy (P = .0001) and from 41.5 Gy to 38.4 Gy (P < .0001), respectively. In addition to OAR sparing, 10 of 29 patients experienced suboptimal target coverage when conventional margin dose distributions were applied to weekly adapted contours, with 5 patients showing consistent underdosing and CTV D98% below 50 Gy, highlighting the importance of adaptation for maintaining target coverage. CONCLUSIONS: The UNITED small-margin weekly adaptive treatment protocol for glioblastoma improves OAR sparing and reduces the irradiated normal brain volume while maintaining consistent target coverage.
引用
- Mann T, Stewart J, Safavi AH, et al. Evaluation of Organs-at-Risk Sparing for Glioblastoma Patients Using a Small-Margin Weekly Adaptive Protocol on a 1.5T MR-Linac. Int J Radiat Oncol Biol Phys. 2026. PMID: 41720169. doi:10.1016/j.ijrobp.2026.02.217
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。